Therapy of Autoimmune Liver Disease


Autoimmune hepatitis is a disease in which the body’s own immune system attacks the liver and causes it to become inflamed. The disease is chronic, meaning it lasts many years. If untreated, it can lead to cirrhosis and liver failure. There are two forms of this disease. Autoimmune hepatitis is characteristically responsive to corticosteroids, often used in combination with azathioprine to obtain a steroid-sparing effect. Therefore, autoimmune liver diseases are presently treated by suppression of the immune response.


    Related Conference of Therapy of Autoimmune Liver Disease

    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    January 26-27, 2027

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2027

    16th World Heart Congress

    Paris, France
    April 27-28, 2027

    5th International Conference on World Heart Care

    Paris, France
    May 12-13, 2027

    42nd World Cardiology Conference

    London, UK
    May 13-14, 2027

    10th Annual Heart Rhythm Conference

    Rome, Italy
    June 17-18, 2027

    10th World Heart and Brain Conference

    London, UK
    June 21-22, 2027

    8th European Summit on Cardiology Research

    Zurich, Switzerland

    Therapy of Autoimmune Liver Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in